Clinical Trial Results: A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PF-07220060 with letrozole versus letrozole alone in postmenopausal women with breast cancer; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• PF-07220060

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-15